House Passes Bill To Cap Out-of-Pocket Insulin Costs To No More Than $35/Month
The House of Representatives voted to approve legislation that would limit cost-sharing for insulin under private health insurance and Medicare.
Peering Into Cigna Corporation’s Recent Short Interest
Cigna Corporation's (NYSE:CI) short percent of float has risen 7.22% since its last report. The company recently reported that it has 3.30 million shares sold short, which is 1.04% of all regular shares that are available for trading.
If You Invested $1000 In This Stock 20 Years Ago, Here’s How Much You Would Have Today
Cigna (NYSE:CI) has outperformed the market over the past 20 years by 3.54% on an annualized basis.
10 Biggest Price Target Changes For Wednesday
Stephens & Co. cut the price target on SmileDirectClub, Inc. (NASDAQ: SDC) from $5 to $3. SmileDirectClub shares fell 3.7% to trade at $1.9650 on Wednesday.
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
SVB Leerink Maintains Market Perform on Cigna, Raises Price Target to $245
SVB Leerink analyst Whit Mayo maintains Cigna (NYSE:CI) with a Market Perform and raises the price target from $224 to $245.
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
RBC Capital Downgrades Cigna to Sector Perform, Lowers Price Target to $235
RBC Capital analyst Frank Morgan downgrades Cigna (NYSE:CI) from Outperform to Sector Perform and lowers the price target from $304 to $235.
Expert Ratings For Cigna
Analysts have provided the following ratings for Cigna (NYSE:CI) within the last quarter: